The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Vaxican sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 8200 PLN
2021 - 2300000 PLN
2022 - 4600000 PLN
2023 - 464700 PLN
2024 - 42200 PLN
+ workforce (estimated if not reported)
2024 - 1
+ depreciation & amortization
2020 - 0
2021 - 1600 PLN
2022 - 28200 PLN
2023 -47200 PLN
2024 - 107100 PLN
Vaxican is a Polish biotech startup advancing next-generation immunotherapies, especially for cancer, and providing genomic sequencing services using Oxford Nanopore technology. Their mission is to develop synergistic immunotherapies and innovative virus-like particles as cancer vaccines, as well as provide high-level research and molecular diagnostics.